Medpace Holdings Inc buy UBS Group AG
Start price
15.02.24
/
50%
€369.50
Target price
15.02.25
€419.64
Performance (%)
-11.48%
End price
16.02.25
€327.10
Summary
This prediction ended on 16.02.25 with a price of €327.10. The price of Medpace Holdings Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.48%. UBS_Group_AG has a follow-up prediction for Medpace Holdings Inc, but this time predicts that Medpace Holdings Inc is a Sell. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Medpace Holdings Inc | 2.053% | 2.053% | 67.843% |
| iShares Core DAX® | 0,79 % | 1,97 % | 13,39 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % | 39,72 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % | 49,89 % |
| iShares S&P 500 | 2,50 % | 2,76 % | 30,23 % |
Comments by UBS_Group_AG for this prediction
In the thread Medpace Holdings Inc diskutieren
Medpace Holdings, Inc. (NASDAQ: MEDP) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $452.00 price target on the stock, up previously from $282.00.
Ratings data for MEDP provided by MarketBeat
In the thread Trading Medpace Holdings Inc
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Medpace Holdings Inc
Medpace Holdings Inc
Start price
Target price
Perf. (%)
€377.20
29.07.25
29.07.25
€263.00
29.07.26
29.07.26
15.96%
16.04.26
16.04.26
